论文信息 - 1740P Track and treat in NSCLC (TATIN) - ctDNA guided treatment of early resistance to second-line osimertinib treatment in patients with EGFR mutation positive (EGFRm) NSCLC - 字舞流文

1740P Track and treat in NSCLC (TATIN) - ctDNA guided treatment of early resistance to second-line osimertinib treatment in patients with EGFR mutation positive (EGFRm) NSCLC

Jan van der Wel | P. Baas | E. Wall | K. Monkhorst | S. Burgers | M. Boelens | E. Smit | L. Steinbusch | M. Jebbink | A. D. Langen | M. Stellingwerf | D. Broek | L. Kastelijn | G. Ruiter